CDK4/6	Cyclin-dependent kinases 4 and 6
CT	Chemotherapy
CTRT	Concurrent chemoradiotherapy
DSS	Disease-specific survival
EC	Endometrial cancer
ER	Estrogen receptor
ESGO	European Society of Gynecological Oncology
ESMO	European Society for Medical Oncology
ESP	European Society of Pathology
ESTRO	European Society for Radiotherapy and Oncology
FDA	Food and Drug Administration
FIGO	International Federation of Gynecology and Obstetrics
FST	Fertility-sparing treatment
HER2	Human epidermal growth factor receptor
HRD	Homologous recombination deficiency
ICI	Immune checkpoint inhibitors
IHC	Immunohistochemistry
L1CAM	L1-cell adhesion molecule
LPS	Laparoscopic
LPT	Laparotomic
LSVI	Lymphovascular space invasion
MMR	Mismatch repair
MMRd	Mismatch repair deficiency
NSMP	Nonspecific molecular subtype
ORR	Objective response rate
OS	Overall survival
PARP	Poly-ADP ribose polymerase
PFS	Progression free survival
PR	Progesterone receptor
ProMise	Proactive Molecular Risk Classifier for Endometrial Cancer
QALY	Quality-adjusted life-year
RFS	Relapse-free survival
RT	Radiotherapy
TCGA	The Cancer Genome Atlas
TH/BSO	Bilateral Slapingo-oophorectomy
TMT	Tumor molecular testing